Cargando…
Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibition
The hepatocyte growth factor (HGF)/MET signaling pathway has been proposed to be involved in the resistance to radiotherapy of glioblastoma via proinvasive and DNA damage response pathways. Here we assessed the role of the MET pathway in the response to radiotherapy in vitro and in vivo in syngeneic...
Autores principales: | Silginer, Manuela, Papa, Eleanna, Szabó, Emese, Vasella, Flavio, Pruschy, Martin, Stroh, Christopher, Roth, Patrick, Weiss, Tobias, Weller, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009975/ https://www.ncbi.nlm.nih.gov/pubmed/36915128 http://dx.doi.org/10.1186/s40478-023-01527-8 |
Ejemplares similares
-
Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma
por: Papa, Eleanna, et al.
Publicado: (2017) -
Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma
por: Hänsch, Lena, et al.
Publicado: (2023) -
CD95 gene deletion may reduce clonogenic growth and invasiveness of human glioblastoma cells in a CD95 ligand-independent manner
por: Quijano-Rubio, Clara, et al.
Publicado: (2022) -
Interferon-β sensitizes human glioblastoma cells to the cyclin-dependent kinase inhibitor, TG02
por: Lohmann, Birthe, et al.
Publicado: (2020) -
Interferon-β exposure induces a fragile glioblastoma stem cell phenotype with a transcriptional profile of reduced migratory and MAPK pathway activity
por: Lohmann, Birthe, et al.
Publicado: (2020)